Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced today that it will report ...
Earlier in March 2026, Guardant Health announced that its FDA-approved Shield blood-based colorectal cancer screening test is ...
New Jersey-based Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic information services, offering a ...
Helio Genomics and Quest Diagnostics have partnered to expand access to a blood-based liver cancer test across the U.S.
Zacks Investment Research on MSN
Quest Diagnostics (DGX) down 4.2% since last earnings report: Can it rebound?
A month has gone by since the last earnings report for Quest Diagnostics (DGX). Shares have lost about 4.2% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...
Quest Diagnostics (DGX) has delivered a 16.19% change over the past year, with a 52-week range between 157.20 and 213.50. What Is the Average Daily Trading Volume of Quest Diagnostics (DGX)? The ...
Quest Diagnostics Incorporated (NYSE: DGX), a leading provider of diagnostic information services, today announced that its board of directors ...
Helio Genomics, an AI-powered TechBio company focused on early cancer detection, today announced an agreement with Quest ...
The deal expands the local firm’s footprint as Quest exits market. #NewsismyBusiness - Stay updated with the latest Puerto ...
Investors in Quest Diagnostics Incorporated DGX need to pay close attention to the stock based on moves in the options market ...
Michael E. Prevoznik, Senior Vice President and General Counsel at Quest Diagnostics Inc. (NYSE:DGX), has sold a portion of his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results